scispace - formally typeset
K

Kiyotaka Kuzushima

Researcher at Nagoya University

Publications -  102
Citations -  4338

Kiyotaka Kuzushima is an academic researcher from Nagoya University. The author has contributed to research in topics: Cytotoxic T cell & Antigen. The author has an hindex of 36, co-authored 102 publications receiving 4163 citations.

Papers
More filters
Journal ArticleDOI

Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay

TL;DR: The results indicate that the real-time PCR assay is useful for diagnosing symptomatic EBV infection and for monitoring the virus load.
Journal ArticleDOI

Detection of Viral DNA in Neonatal Herpes Simplex Virus Infections: Frequent and Prolonged Presence in Serum and Cerebrospinal Fluid

TL;DR: PCR assay results suggest that HSV may be spread principally via viremia in neonates, especially in culture-negative cases of neonatal HSV infections.
Journal ArticleDOI

Efficient identification of HLA-A*2402–restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay

TL;DR: A major cytomegalovirus (CMV)-specific CTL epitope, QYDPVAALF, in the amino acid sequence of its lower matrix 65 kd phosphoprotein (pp65) presented by HLA-A*2402 molecules was identified and could be a useful reagent to study CTL responses to CMV among populations positive for Hla-A-2402.
Journal ArticleDOI

Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens

TL;DR: The identification of two novel minor histocompatibility antigens (mHAgs), encoded by two separate single nucleotide polymorphisms on a single gene, BCL2A1, and restricted by human histOCompatibility leukocyte antigen (HLA)-A*2402 and B*4403, respectively, is reported.
Journal ArticleDOI

Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases.

TL;DR: Plasma from patients with IM contained the highest amount of virus DNA within 7 days following the onset of disease, and the concentration of EBV DNA in plasma seems to be higher in patients with the more severe clinical categories ofEBV diseases.